Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
Department of Pediatrics, Mayo Clinic, Rochester, MN, USA.
J Child Neurol. 2024 May;39(5-6):218-221. doi: 10.1177/08830738241255247. Epub 2024 May 22.
To document the association of -related disorder (EIEE-50) with cortical visual impairment.
An 8-month-old Caucasian boy with whole genome sequencing confirming 2 variants in the gene , who presented with severe seizures, microcephaly, hyperreflexia, hypotonia, anemia, and severe cortical visual impairment. Magnetic resonance imaging (MRI) of the brain noted thickened cortical gray matter along the right calcarine fissure as well as changes suggesting malformation of cortical development. Empiric uridine monophosphate supplementation has significantly improved seizure activity, hypotonia, and development and has led to resolution of anemia.
-related disorder is treatable and may affect visual cortical development causing severe secondary cortical visual impairment, a newly described clinical manifestation.
记录与 - 相关障碍(EIEE-50)相关的皮质视觉障碍。
一名 8 个月大的白人男孩进行全基因组测序,证实该基因有 2 种变异,表现为严重癫痫、小头畸形、反射亢进、张力减退、贫血和严重皮质视觉障碍。大脑磁共振成像(MRI)显示右侧距状裂沿著增厚的皮质灰质,以及提示皮质发育畸形的变化。经验性尿苷单磷酸补充治疗显著改善了癫痫发作、张力减退和发育,并导致贫血的缓解。